| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.005 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.007 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.008 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.099 | 0.009 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.009 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |